306 related articles for article (PubMed ID: 12687723)
1. Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis.
Sugimoto M; Sadamoto T; Nonaka H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Feb; 38(1):34-45. PubMed ID: 12687723
[TBL] [Abstract][Full Text] [Related]
2. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
3. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
5. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
6. [Sex difference in alcoholic liver disease: with special reference to the severity of alcoholic hepatitis].
Furube M; Sugimoto M; Asakura I; Mizukami H; Akita H; Hatori T; Abei T; Sasaki K
Arukoru Kenkyuto Yakubutsu Ison; 1989 Jun; 24(3):135-43. PubMed ID: 2803107
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.
Gupte P; Amarapurkar D; Agal S; Baijal R; Kulshrestha P; Pramanik S; Patel N; Madan A; Amarapurkar A; Hafeezunnisa
J Gastroenterol Hepatol; 2004 Aug; 19(8):854-8. PubMed ID: 15242486
[TBL] [Abstract][Full Text] [Related]
9. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic findings in patients with nonalcoholic steatohepatitis.
Tanaka N; Ichijo T; Okiyama W; Mutou H; Misawa N; Matsumoto A; Yoshizawa K; Tanaka E; Kiyosawa K
Liver Int; 2006 Feb; 26(1):32-8. PubMed ID: 16420508
[TBL] [Abstract][Full Text] [Related]
11. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
Haukeland JW; Konopski Z; Linnestad P; Azimy S; Marit Løberg E; Haaland T; Birkeland K; Bjøro K
Scand J Gastroenterol; 2005 Dec; 40(12):1469-77. PubMed ID: 16293559
[TBL] [Abstract][Full Text] [Related]
12. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
Harrison SA; Torgerson S; Hayashi PH
Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
[TBL] [Abstract][Full Text] [Related]
13. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
[TBL] [Abstract][Full Text] [Related]
14. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
15. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
Tiniakos DG
Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic steatohepatitis.
Das K; Kar P
J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Miele L; Forgione A; Gasbarrini G; Grieco A
Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
[TBL] [Abstract][Full Text] [Related]
19. Two cases of non-alcoholic steato-hepatitis developing from simple fatty liver.
Kim SR; Nakajima T; Ando K; Mita K; Fukuda K
J Gastrointestin Liver Dis; 2009 Dec; 18(4):491-5. PubMed ID: 20076826
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]